title: Phase III long-term study and comparative clinical study of nipradilol ophthalmic solution in patients with primary open-angle glaucoma and ocular hypertension. Part 2.
authors.affiliation: Department of Ophthalmology, School of Medicine, University of Tokyo, Japan.
authors.forename: Mikiko
authors.initials: M
authors.lastname: Kanno
authors.forename: Makoto
authors.initials: M
authors.lastname: Araie
authors.forename: Kanjiro
authors.initials: K
authors.lastname: Masuda
authors.forename: Masahiro
authors.initials: M
authors.lastname: Takase
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Kitazawa
authors.forename: Yoshihiko
authors.initials: Y
authors.lastname: Shiose
authors.forename: Ikuo
authors.initials: I
authors.lastname: Azuma
authors.forename: Nobuya
authors.initials: N
authors.lastname: Ogawa
authors.forename: Shigehiro
authors.initials: S
authors.lastname: Ohdo
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001794:Blood Pressure / Q000187:drug effects; D004311:Double-Blind Method; D004562:Electrocardiography; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy*; D009883:Ophthalmic Solutions; D011412:Propanolamines / Q000008:administration & dosage* / Q000627:therapeutic use*; D013999:Timolol / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions; D011412:Propanolamines; D013999:Timolol; C036089:nipradilol